The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events.

Affiliation

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein; Division of Angiology, Swiss Cardiovascular Center, University Hospital of Bern, Bern, Switzerland; Drexel University College of Medicine, Philadelphia, PA, USA. Electronic address: [Email]

Abstract

The recently identified adiponectin paralogue C1q and tumor necrosis factor-related protein 1 (CTRP1) has been associated with obesity-linked disorders and coronary atherosclerosis. So far, the impact of circulating CTRP1 on the incidence of future cardiovascular events is unclear. Therefore, we aimed at investigating the association between CTRP1 and future cardiovascular risk.

Keywords

Adipokine,CTRP1,Major adverse cardiovascular events,Prospective study,Risk factor,

OUR Recent Articles